DKK1 and osteogenesis imperfecta: Our studies demonstrated that serum DKK1 concentration was significantly higher in OI patients, which could inhibit the activity of the WNT pathway, leading to a decrease in the expression of multiple genes in osteoblasts, reduce differentiation and maturation of osteoblasts, and inhibit bone formation.